Economic Analysis of Extended Cytomegalovirus Prophylaxis in High Risk Kidney Transplant Patients.

被引：0
|
作者：
Luan, Fu Lung [1 ]
Stucky, Linda [1 ]
Park, Jeong M. [1 ]
Ojo, Akinlolu [1 ]
机构：
[1] Univ Michigan, Coll Pharm, Ann Arbor, MI 48109 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2009年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：250 / 250
页数：1
相关论文
共 50 条
  • [1] Prophylaxis of cytomegalovirus disease in high-risk patients.
    Scholz, M
    Cinatl, J
    Doerr, W
    INFECTION, 1997, 25 (05) : 269 - 273
  • [2] Tailoring cytomegalovirus prophylaxis based on T cell immunity panel assessment in kidney transplant patients at high risk of cytomegalovirus
    Servais, Abigail M.
    McMullen, John S.
    Bowen, Riley
    Kleiboeker, Steven B.
    Ulloa, Isabelle
    Duncan, Kara
    Miles, Clifford D.
    TRANSPLANT INFECTIOUS DISEASE, 2024, 26 (04)
  • [3] Cytomegalovirus prophylaxis by passive immunization in high-risk kidney and heart transplant recipients
    Weimar, W
    Metselaar, HJ
    Balk, AHMM
    IMMUNE CONSEQUENCES OF TRAUMA, SHOCK AND SEPSIS - MECHANISMS AND THERAPEUTIC APPROACHES, VOL II, PTS 1 AND 2, 1996, : 587 - 591
  • [4] Early versus Delayed Cytomegalovirus Prophylaxis in High-Risk Kidney Transplant Recipients
    Hutchins, A.
    Leick, M.
    Keck, M.
    McMullen, J. S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 780 - 781
  • [5] Cytomegalovirus prophylaxis with valganciclovir in cytomegalovirus-seropositive kidney-transplant patients
    Weclawiak, Hugo
    Kamar, Nassim
    Mengelle, Catherine
    Guitard, Joelle
    Esposito, Laure
    Lavayssiere, Laurence
    Cointault, Olivier
    Ribes, David
    Rostaing, Lionel
    JOURNAL OF MEDICAL VIROLOGY, 2008, 80 (07) : 1228 - 1232
  • [6] PROPHYLAXIS AGAINST CYTOMEGALOVIRUS IS ASSOCIATED WITH LOWER KIDNEY FUNCTION IN TRANSPLANT PATIENTS WITH INTERMEDIATE REACTIVATION RISK
    Blazquez-Navarro, A.
    Dang-Heine, C.
    Bauer, C.
    Wittenbrink, N.
    Wolk, K.
    Sabat, R.
    Westhoff, T. H.
    Sawitzki, B.
    Reinke, P.
    Thomusch, O.
    Hugo, C.
    Or-Guil, M.
    Babel, N.
    TRANSPLANT INTERNATIONAL, 2018, 31 : 34 - 34
  • [7] SHORT VERSUS EXTENDED TERM VALGANCICLOVIR PROPHYLAXIS FOR CYTOMEGALOVIRUS INFECTION IN PEDIATRIC KIDNEY TRANSPLANT
    Hashim, Faris
    Dharnidharka, Vikas
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2013, 61 (04) : A45 - A45
  • [8] Individualization of Valganciclovir Prophylaxis for Cytomegalovirus Infection in Pediatric Kidney Transplant Patients
    Zhao, Wei
    Fakhoury, May
    Fila, Marc
    Baudouin, Veronique
    Deschenes, Georges
    Jacqz-Aigrain, Evelyne
    THERAPEUTIC DRUG MONITORING, 2012, 34 (03) : 326 - 330
  • [9] The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High-Risk Kidney Transplant Recipients
    Humar, A.
    Lebranchu, Y.
    Vincenti, F.
    Blumberg, E. A.
    Punch, J. D.
    Limaye, A. P.
    Abramowicz, D.
    Jardine, A. G.
    Voulgari, A. T.
    Ives, J.
    Hauser, I. A.
    Peeters, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 (05) : 1228 - 1237
  • [10] Efficacy of low dose ganciclovir prophylaxis for cytomegalovirus disease in a high risk kidney transplant population.
    Velarde, CM
    Ismail, K
    Ramos, M
    Serpa, J
    Parasuraman, R
    Goggins, M
    Venkat, KK
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 428A - 428A
12345